Sepsis Assessment in Belgian Emergency Rooms
NCT02424721 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2019-01-09
Summary
To validate the use of the Heparin Binding Protein (HBP) concentration to assist in the evaluation of patients admitting to the emergency department with suspected infection.
Conditions
- Sepsis
- Shock, Septic
- Severe Sepsis
Sponsors & Collaborators
-
Axis Shield Diagnostics Ltd
lead INDUSTRY
Principal Investigators
-
Jean-Louis Vincent, MD · Erasme University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-05-31
- Primary Completion
- 2018-12-31
- Completion
- 2018-12-31
Countries
- Belgium
Study Locations
More Related Trials
-
Sepsis, Severe Sepsis and Septic Shock Detection by Breath Analysis
NCT03497182 ·Status: COMPLETED ·Phase: NA
-
Effect of Albumin Administration on Vasopressor Duration in Resolving Septic Shock
NCT02716597 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluation of Plasma Angiotensin II and Angiotensin II Receptor Levels in Patients With Sepsis and Septic Shock: a Prospective Observational Study.
NCT04716842 ·Status: UNKNOWN
-
Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis
NCT05681442 ·Status: RECRUITING ·Phase: PHASE4
-
Molecular Diagnosis and Risk Stratification of Sepsis in India
NCT03727243 ·Status: UNKNOWN
-
Hemospec Device for Sepsis Diagnosis
NCT03350113 ·Status: COMPLETED ·Phase: NA
-
Sepsis Early EvaluatioN Through Rapid Ultrasound and veNous Gas Analysis
NCT05787184 ·Status: UNKNOWN
-
Interest of the Balance of Pro-coagulating and Profibrinolytis Activities of the Microparticles (MP) in the Prognosis of Septic Shock
NCT02062970 ·Status: UNKNOWN ·Phase: NA
-
Viscoelastic Coagulation for Early Sepsis Detection
NCT07073456 ·Status: RECRUITING
-
Haemofiltration Study : IVOIRE (hIgh VOlume in Intensive Care)
NCT00241228 ·Status: COMPLETED ·Phase: NA
-
Predict Sepsis; the Predictive Value of Bedside Measures in the Ambulance
NCT03249597 ·Status: COMPLETED
-
Procurement of Human Specimens for the Evaluation of Early Markers of Sepsis
NCT01746407 ·Status: COMPLETED
-
Albumin Replacement Therapy in Septic Shock
NCT03869385 ·Status: TERMINATED ·Phase: PHASE3
-
Early Detection of At-risk Septic Patients
NCT06253325 ·Status: RECRUITING
-
Comparison of Sensitivity Between Presepsine and Lactate for the Diagnosis of Severe Sepsis.
NCT02300415 ·Status: UNKNOWN
-
Rapid Molecular Diagnosis of Sepsis in the Intensive Care Unit
NCT06624618 ·Status: RECRUITING
-
Hemodynamic and Perfusion Response to Drotrecogin Alfa (Activated) in Patients With Septic Shock
NCT00279214 ·Status: COMPLETED ·Phase: PHASE4
-
Biomarkers for the Early Identification of Sepsis in the Emergency Department
NCT02707718 ·Status: COMPLETED
-
Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock
NCT00604214 ·Status: COMPLETED ·Phase: PHASE3
-
Relation Between Mean Arterial Pressure and Renal Resistive Index in the Early Phase of Septic Shock
NCT04281277 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Parameters Collected From Routine Data for the Diagnosis of Sepsis and Septic Shock and Their Influence on Time to Diagnosis and Patient Outcome
NCT05383963 ·Status: RECRUITING
-
A STUDY BEFORE/AFTER THE IMPLEMENTATION OF AN ANTI-INFECTIOUS PRESCRIPTION AID
NCT05140213 ·Status: COMPLETED
-
A Trial of Heparin in Patients With Severe Sepsis Who Are Undergoing Treatment With Drotrecogin Alfa (Activated)
NCT00049777 ·Status: COMPLETED ·Phase: PHASE4
-
Heparin Anticoagulation in Septic Shock
NCT03378466 ·Status: TERMINATED ·Phase: PHASE2
-
Hemospec Device for the Diagnosis of Sepsis
NCT03306186 ·Status: COMPLETED ·Phase: NA